Understanding Michigan’s New Wholesale Cannabis Tax Guidance
Michigan wholesale cannabis tax guidance introduces new regulatory challenges affecting cannabis pricing and patient access. These changes may impact treatment adherence and continuity. Healthcare providers should monitor these developments closely.
Cannabis Working Group Debate Pulled – Clinical Impact
Cannabis policy instability continues to impact patient access to medical cannabis and complicates clinician treatment decisions. This ongoing regulatory uncertainty challenges consistent therapeutic recommendations. Healthcare providers must stay…
Cannabis Working Group Debate Postponed Amid Policy Delays
Cannabis policy development delays are causing prolonged regulatory uncertainty that impacts clinical practice. These delays affect prescribing protocols and patient access to standardized cannabis products. Clinicians require clear cannabis medicine…
Top Cannabis Stocks To Keep An Eye On – March 21st – MarketBeat
Cannabis stock performance reflects industry stability and capital flow, which directly impacts medication availability and research funding. Market volatility can affect patient access to consistent, regulated products. Understanding cannabis stock…
Cannabis Companies Ended 2025 with Weakening Financial Positions
Industry financial instability cannabis trends in 2025 are impacting patient access and product quality. Cannabis companies face financial challenges that affect product availability and testing. This instability poses risks for consistent medical…
Gov. Braun says reform possible on state’s cannabis laws – WFYI
Indiana cannabis reform took a step forward when Governor Braun signaled openness to reconsidering the state's restrictive medical cannabis laws. Indiana currently limits legal access to CBD products for epilepsy, leaving patients with chronic pain,…
Red Lake Nation Launches Cannabis Dispensary Under Tribal Sovereignty
The Red Lake Nation has opened a cannabis dispensary operating under tribal sovereignty cannabis commerce. This unique regulatory environment affects patient access and product standards. Clinicians should understand these differences when advising…
Audit Uncovers Violations in Alabama Medical Cannabis Commission
The Alabama Medical Cannabis Commission audit highlights significant financial violations and oversight concerns. These findings raise questions about regulatory effectiveness in Alabama's medical cannabis program. Patients and clinicians should monitor…
Why Cannabis Rescheduling Alone Won’t Stabilize the Industry
The cannabis rescheduling impact could remove federal barriers to clinical research, enabling better prescribing decisions. However, without regulatory clarity, product consistency remains a challenge. Cannabis rescheduling impact alone won't stabilize…